Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

M.B. Overdijk, S. Verploegen, M. Bögels, M. van Egmond, J.J.L. van Bueren, T. Mutis, R.W.J. Groen, E. Breij, A.C.M. Martens, W.K. Bleeker, P.W.H.I. Parren

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)311-320
JournalMABS
Volume7
Issue number2
DOIs
Publication statusPublished - 2015

Cite this